FellowshipEmpowering future biotech entrepreneurs and investors through hands-on venture capital education.

M Ventures is the corporate venture capital fund of Merck KGaA, based in Amsterdam, Netherlands. It invests in biotechnology and technology companies that align with Merck's strategic interests in healthcare, life sciences, and electronics.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
M Ventures is the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany, founded in 2009 and headquartered in Amsterdam, Netherlands. The fund operates as an evergreen vehicle, allowing it to invest across market cycles without a fixed fund life. M Ventures focuses on transformative ideas in biotechnology and technology, supporting companies that address complex challenges in healthcare, life science tools, electronics, and frontier technology & sustainability. The fund aims to achieve both strategic alignment with Merck's core business areas and strong financial returns through exits. Since its inception, M Ventures has been involved in the creation, financing, and management of over 80 global companies, with a commitment of €600 million announced in December 2021 for deployment over five years.
M Ventures focuses on investing in companies innovating in healthcare drug development, life science tools, electronics, and frontier technology & sustainability. The fund seeks to back visionary companies that can deliver both strategic and financial returns, addressing significant challenges in these sectors.
M Ventures provides strategic support to its portfolio companies by leveraging the resources and expertise of Merck KGaA. This includes access to industry knowledge, potential partnerships, and a network that can facilitate growth and innovation in the healthcare and technology sectors.
Superscout Pro
Is this page right?Reviewed · How the research works